StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > News release

<< Previous

Bullboard Posts

Next >>

Comment by Photoman77on Aug 18, 2022 10:34am

120 Views

Post# 34904653

RE:News release

Not useless as it diverts focus here:

AVRT and COC w/Aristotle is now ready for full operation and taking on employer groups.

Tripp has indicated most are literally beginning now as we speak so expect Q3 and especially Q4 to see significant volume which equates to significant revenu increase those quarters.

<< Previous

Bullboard Posts

Next >>

Investing with insurance and protection